JHIU
VYGR icon

Janus Henderson Investors US’s Voyager Therapeutics VYGR Stock Holding History

Janus Henderson Investors US’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-263,074
Closed -$2.89M – 1231
2016
Q2 		$2.89M Sell
263,074
-42,027
-14% -$514K ﹤0.01% 854
2016
Q1 		$2.66M Sell
305,101
-138,685
-31% -$1.57M ﹤0.01% 870
2015
Q4 		$9.72M Buy
+443,786
New +$10.2M 0.01% 714

Other funds holding VYGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Investors US's VYGR Position: Q3 2016 in Review

Janus Henderson Investors US sold out of Voyager Therapeutics (VYGR) in Q3 2016, closing a stake of 263,074 shares — an estimated $2.89M sold.

Janus Henderson Investors US first reported a position in VYGR in Q4 2015 and held it in 3 quarters. The position peaked at $9.72M in Q4 2015. 52 funds tracked by Wall St. Rank hold VYGR as of Q3 2016.

  • Janus Henderson Investors US reported no remaining Voyager Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Janus Henderson Investors US sold 263,074 Voyager Therapeutics shares in Q3 2016, an estimated $2.89M.
  • Janus Henderson Investors US first reported a position in Voyager Therapeutics in Q4 2015 and held it in 3 quarters.
  • Janus Henderson Investors US's Voyager Therapeutics position peaked at $9.72M in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2016.

Based on Janus Henderson Investors US's 13F filing for Q3 2016, filed 14 Nov 2016.